Chemotherapy for metastatic tumors to the central nervous system
- PMID: 11595117
- DOI: 10.1007/s11912-001-0070-z
Chemotherapy for metastatic tumors to the central nervous system
Abstract
Management of patients with central nervous system metastases poses numerous challenges. This review focuses on the use of chemotherapy in these patients, addressing treatment difficulties such as drug resistance and possible solutions. The impact of the blood-brain barrier is considered less of a limitation than once thought. The advent of targeted signal transduction inhibitors is noted in this context. The current efficacy of chemotherapeutic agents and combinations is also discussed, with results from large studies highlighting a positive survival trend for chemotherapy in selected tumor histologies.
Similar articles
-
Combining etoposide and dexrazoxane synergizes with radiotherapy and improves survival in mice with central nervous system tumors.Clin Cancer Res. 2005 Sep 15;11(18):6722-9. doi: 10.1158/1078-0432.CCR-05-0698. Clin Cancer Res. 2005. PMID: 16166453
-
Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.Cancer. 2008 Feb 1;112(3):581-8. doi: 10.1002/cncr.23221. Cancer. 2008. PMID: 18072268 Clinical Trial.
-
Primary central nervous system lymphoma: curable without toxicity?Cancer J Sci Am. 1996 May-Jun;2(3):137-9. Cancer J Sci Am. 1996. PMID: 9166513 Review. No abstract available.
-
Treatment of intracranial metastatic esthesioneuroblastoma.J Clin Oncol. 2002 Jan 1;20(1):357-8. doi: 10.1200/JCO.2002.20.1.357. J Clin Oncol. 2002. PMID: 11773199 Clinical Trial. No abstract available.
-
Primary central nervous system lymphoma: biological aspects and controversies in management.Eur J Cancer. 2007 May;43(7):1141-52. doi: 10.1016/j.ejca.2006.12.011. Epub 2007 Apr 12. Eur J Cancer. 2007. PMID: 17433666 Review.
Cited by
-
Pyrotinib as a therapeutic for HER2-positive breast cancer.Transl Cancer Res. 2023 Jun 30;12(6):1376-1379. doi: 10.21037/tcr-23-333. Epub 2023 Jun 1. Transl Cancer Res. 2023. PMID: 37434682 Free PMC article. No abstract available.
-
The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs.Int J Cancer. 2011 Jun 1;128(11):2527-35. doi: 10.1002/ijc.26031. Epub 2011 Mar 25. Int J Cancer. 2011. PMID: 21365651 Free PMC article. Review.
-
Self-Assembly of Gold Nanoparticles Shows Microenvironment-Mediated Dynamic Switching and Enhanced Brain Tumor Targeting.Theranostics. 2017 Apr 10;7(7):1875-1889. doi: 10.7150/thno.18985. eCollection 2017. Theranostics. 2017. PMID: 28638474 Free PMC article.
-
New developments in brain metastases.Ther Adv Neurol Disord. 2018 Jun 28;11:1756286418785502. doi: 10.1177/1756286418785502. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 30034538 Free PMC article. Review.
-
Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis.ESMO Open. 2022 Jun;7(3):100501. doi: 10.1016/j.esmoop.2022.100501. Epub 2022 May 30. ESMO Open. 2022. PMID: 35653982 Free PMC article.